KOPRAN
|
The Current P/B Ratio of KOPRAN is 3.19.
Share Price | ₹324.3 | Sep 19,2024 |
Market Cap | ₹1,562.9 Cr | |
Book Value | ₹490.2 Cr | Mar2024 - Consolidated Results |
Price/Book | 3.19x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹1,562.9 Cr] as on Sep 19,2024
(/) Book Value [ ₹490.2 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 3.19x ]
Thus, for KOPRAN , the investors are currently willing to pay '3.19 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.87x.
- KOPRAN 's operated at median p/b ratio of 1.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2020 of 0.58x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
KOPRAN | 490.21 | 3.19 | 1,562.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.96 | 443,025.0 |
CIPLA LTD | 26,619.90 | 4.97 | 132,316.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.86 | 108,579.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.35 | 106,092.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 10.63 | 144,299.0 |
MANKIND PHARMA LTD | 9,339.84 | 10.43 | 97,396.6 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.54 | 113,401.0 |
LUPIN LTD | 14,175.80 | 6.98 | 98,990.9 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.97 | 88,708.7 |
ABBOTT INDIA LTD | 3,658.73 | 16.24 | 59,419.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.97x |
Max industry PB | 16.54x |
Median industry PB | 6.96x |
Average industry PB | 8.01x |
You may also like the below Video Courses